Related Scientific Literature
- Evaluation of nine commercial SARS-CoV-2 immunoassays
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland
- Testing for COVID-19: A few points to remember
- Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
- Evaluation of commercially available immuno-magnetic agglutination and enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19
- Performance of Abbott Architect, Ortho Vitros, and Euroimmun Assays in Detecting Prior SARS-CoV-2 Infection
- RT-PCR testing to detect a COVID-19 outbreak in Austria: rapid, accurate and early diagnosis in primary care (The REAP study)
- Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays?
- Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
- Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies
- Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
- In vitro diagnostics of coronavirus disease 2019: Technologies and application
- SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons
- Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays
- Performance characteristics of four high-throughput immunoassays for detection of igg antibodies against sars-cov-2
- Rapid quantification of SARS-CoV-2-neutralizing antibodies using propagation-defective vesicular stomatitis virus pseudotypes
- Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
- Antibody tests in detecting SARS-CoV-2 infection: A meta-analysis
- Clinical performance of different SARS-CoV-2 IgG antibody tests
- Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies
- Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
- Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?
- Testing For SARS-CoV-2: The Day the World Turned its Attention to the Clinical Laboratory
- How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing
- Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test
- Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
- Comparison of different serological assays for SARS-CoV-2 in real life
- Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
- Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients
- Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody
- Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection
- Validation of a commercially available SARS-CoV-2 serological immunoassay
- Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
- Review of Current Advances in Serologic Testing for COVID-19
- Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- Antibody response using six different serological assays in a completely PCR-tested community after a COVID-19 outbreak - the CoNAN study
- Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
- Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests
- Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans
- Performance of a qualitative rapid chromatographic immunoassay to diagnose COVID-19 in patients in a middle-income country
- Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays
- Clinical Performance of Two SARS-CoV-2 Serologic Assays
- Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests
- Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting
- Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies
- Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples
- EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
- Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests
- Sensitivity of the Wondfo One Step COVID-19 test using serum samples
- Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study
- Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event
- Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.
- Evaluation of ELISA tests for the qualitative determination of IgG, IgM and IgA to SARS-CoV-2
- Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent sera
- Comparison of SARS-CoV-2 serological tests with different antigen targets
- Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories
- Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
- Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with
- Overcoming Supply Shortage for SARS-CoV-2 Detection by RT-qPCR.
- Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection Colombia.
- Performance of SARS-CoV-2 serology tests: Are they good enough?
- Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.
- Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening.
- Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection.